These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8167104)

  • 1. Culture of tissue-cyst forming strain of Toxoplasma gondii and the effect of cyclic AMP and pyrimidine salvage inhibitors.
    Choi WY; Park SK; Nam HW; Kim DJ
    Korean J Parasitol; 1994 Mar; 32(1):19-26. PubMed ID: 8167104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii Cyclic AMP-Dependent Protein Kinase Subunit 3 Is Involved in the Switch from Tachyzoite to Bradyzoite Development.
    Sugi T; Ma YF; Tomita T; Murakoshi F; Eaton MS; Yakubu R; Han B; Tu V; Kato K; Kawazu S; Gupta N; Suvorova ES; White MW; Kim K; Weiss LM
    mBio; 2016 May; 7(3):. PubMed ID: 27247232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected oocyst shedding by cats fed Toxoplasma gondii tachyzoites: in vivo stage conversion and strain variation.
    Dubey JP
    Vet Parasitol; 2005 Nov; 133(4):289-98. PubMed ID: 16024176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell culture system for study of the development of Toxoplasma gondii bradyzoites.
    Weiss LM; Laplace D; Takvorian PM; Tanowitz HB; Cali A; Wittner M
    J Eukaryot Microbiol; 1995; 42(2):150-7. PubMed ID: 7757057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide signaling in Toxoplasma gondii bradyzoite differentiation.
    Kirkman LA; Weiss LM; Kim K
    Infect Immun; 2001 Jan; 69(1):148-53. PubMed ID: 11119500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pyrimidine salvage inhibitors on uracil incorporation of Toxoplasma gondii.
    Youn JH; Nam HW; Kim DJ; Choi WY
    Kisaengchunghak Chapchi; 1990 Jun; 28(2):79-84. PubMed ID: 2271504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: studies by light and electron microscopy. Consequences for chemotherapy.
    Werner H; Matuschka FR; Brandenburg I
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):240-53. PubMed ID: 44617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
    Bohne W; Heesemann J; Gross U
    Infect Immun; 1994 May; 62(5):1761-7. PubMed ID: 8168938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
    Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
    J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells.
    Tanaka T; Omata Y; Saito A; Shimazaki K; Igarashi I; Suzuki N
    J Vet Med Sci; 1996 Jan; 58(1):61-5. PubMed ID: 8645758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibitory effect of bovine lactoferrin to Toxoplasma gondii tachyzoites in murine macrophages: tyrosine phosphorylation in murine macrophages induced by bovine lactoferrin.
    Tanaka T; Omata Y; Isamida T; Saito A; Shimazaki K; Yamauchi K; Suzuki N
    J Vet Med Sci; 1998 Mar; 60(3):369-71. PubMed ID: 9560789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii cyst wall formation in activated bone marrow-derived macrophages and bradyzoite conditions.
    Tobin C; Pollard A; Knoll L
    J Vis Exp; 2010 Aug; (42):. PubMed ID: 20736916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii infection in the peritoneal macrophages of rats treated with glucocorticoids.
    Wang T; Gao JM; Yi SQ; Geng GQ; Gao XJ; Shen JL; Lu FL; Wen YZ; Hide G; Lun ZR
    Parasitol Res; 2014 Jan; 113(1):351-8. PubMed ID: 24248630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary culture of skeletal muscle cells as a model for studies of Toxoplasma gondii cystogenesis.
    Guimarães EV; de Carvalho L; Barbosa HS
    J Parasitol; 2008 Feb; 94(1):72-83. PubMed ID: 18372624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii.
    El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
    Acta Trop; 2015 Jan; 141(Pt A):103-11. PubMed ID: 25305510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of IL-6 on the multiplication of Toxoplasma gondii].
    Fang Y; Tan Y; Zhang Y; Li J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):106-8. PubMed ID: 12563793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic acid induces differentiation of Toxoplasma gondii RH strain tachyzoites into bradyzoites and formation of cyst-like structure in vitro.
    Castro-Elizalde KN; Hernández-Contreras P; Ramírez-Flores CJ; González-Pozos S; Gómez de León CT; Mondragón-Castelán M; Mondragón-Flores R
    Parasitol Res; 2018 Feb; 117(2):547-563. PubMed ID: 29308550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prednisolone to aid propagation of Toxoplasma gondii in mice.
    Puvanesuaran VR; Nowroji K; Sreenivasan S; Noordin R; Balakrishnan V
    Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):1028-32. PubMed ID: 22913152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.